| Current Price | $6.21 | Mkt Cap | $167.7M |
|---|---|---|---|
| Open | $6.26 | P/E Ratio | -3.45 |
| Prev. Close | $6.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.18 - $6.36 | Volume | 162,805 |
| 52-Wk Range | $5.87 - $15.12 | Avg. Daily Vol. | 166,820 |
| Current Price | $6.21 | Mkt Cap | $167.7M |
|---|---|---|---|
| Open | $6.26 | P/E Ratio | -3.45 |
| Prev. Close | $6.21 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.18 - $6.36 | Volume | 162,805 |
| 52-Wk Range | $5.87 - $15.12 | Avg. Daily Vol. | 166,820 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative play. 0.85 is a hard resistance, if breaks out, could see 1.3-1.5 in 6 months
Stage 3 cancer drug research is not living up to promises.
Read the most recent pitches from players about ATNM.
Recs
genedom
(77.19)
Submitted: 10/18/2018 2:36:37 PM :
Start Price:
$0.73
NYSE MKT:ATNM Score:
+691.86
Speculative play. 0.85 is a hard resistance, if breaks out, could see 1.3-1.5 in 6 months
Recs
wisnasty60
(< 20)
Submitted: 7/16/2016 12:08:08 PM :
Start Price:
$1.69
NYSE MKT:ATNM Score:
+167.50
Company with potential breakthrough treatment for older patients with leukemia. Drugs in Phase 2 & 3 trials at the moment.
Recs
fireonice1970
(< 20)
Submitted: 1/28/2015 6:01:48 PM :
Start Price:
$5.76
NYSE MKT:ATNM Score:
+107.89
Stage 3 cancer drug research is not living up to promises.
Find the members with the highest scoring picks in ATNM.
DeathStock (< 20) Score: +742.42
The Score Leader is the player with the highest score across all their picks in ATNM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| DeathStock | < 20 | 7/31/2017 |
|
5Y | $0.68 | +817.15% | +74.73% | +742.42 | 0 Comment | |
| Momentum21 | 22.76 | 10/4/2017 |
|
5Y | $0.70 | +793.53% | +70.88% | +722.64 | 0 Comment | |
| NateVDM214 | < 20 | 6/21/2018 |
|
3M | $0.71 | +774.65% | +56.63% | +718.02 | 0 Comment | |
| zzlangerhans | 37.41 | 10/24/2017 |
|
1Y | $0.72 | +762.50% | +68.45% | +694.05 | 0 Comment | |
| genedom | 77.19 | 10/18/2018 |
|
1Y | $0.73 | +748.36% | +56.50% | +691.86 | 1 Comment | |
| jck444 | 69.51 | 7/18/2017 |
|
5Y | $1.06 | +485.85% | +76.38% | +409.47 | 0 Comment | |
| ptbradford | < 20 | 11/17/2016 |
|
5Y | $1.06 | +486.73% | +97.65% | +389.08 | 0 Comment | |
| wisnasty60 | < 20 | 7/18/2016 |
|
3Y | $1.69 | +267.80% | +100.31% | +167.50 | 1 Comment | |
| BetterWitCheddar | 77.58 | 10/23/2014 |
|
5Y | $7.19 | -13.63% | +122.09% | +135.72 | 0 Comment | |
| YacineNYC | < 20 | 9/26/2016 |
|
5Y | $1.90 | +226.84% | +101.71% | +125.13 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
